Back to search results

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Israel
RecruitingPHASE3

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Oligometastatic Prostate Cancer (OMPC)

Locations
  • Highlands Oncology Group, Fayetteville, Arkansas, United States
  • VA Greater LA Healthcare System, Los Angeles, California, United States
  • VA Palo Alto Health Care System, Palo Alto, California, United States
  • Stanford University, Palo Alto, California, United States
  • UCSF, San Francisco, California, United States
  • Rocky Mountain Cancer Centers, Denver, Colorado, United States
  • Cancer Specialists of North Florida, Jacksonville, Florida, United States
  • Woodlands Medical Specialists, Pensacola, Florida, United States
  • Piedmont Healthcare, Atlanta, Georgia, United States
  • University of Chicago, Chicago, Illinois, United States
  • The Cancer Institute of Alexian Brothers, Elk Grove, Illinois, United States
  • Unity Point Clinic, Des Moines, Iowa, United States
  • University of Kansas Hospital, Kansas City, Kansas, United States
  • Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States
  • East Jefferson Hospital, Metairie, Louisiana, United States
  • University of Maryland Medical Ctr, Baltimore, Maryland, United States
  • Johns Hopkins Kimmel Com Cancer Ctr, Baltimore, Maryland, United States
  • Dana Farber Cancer Institute, Boston, Massachusetts, United States
  • Beth Israel Deaconess Med Ctr, Boston, Massachusetts, United States
  • BAMF Health, Grand Rapids, Michigan, United States
  • Profound Research LLC, Royal Oak, Michigan, United States
  • William Beaumont Hospital, Royal Oak, Michigan, United States
  • Mayo Clinic Rochester, Rochester, Minnesota, United States
  • VA St Louis Health Care System, St Louis, Missouri, United States
  • Wash U School of Medicine, St Louis, Missouri, United States
  • Adult and Pedi Urology and Urogyne, Omaha, Nebraska, United States
  • Memorial Sloan Kettering Cancer Ctr, New York, New York, United States
  • Associated Med Professionals of NY, Syracuse, New York, United States
  • Montefiore Hospital, The Bronx, New York, United States
  • East Carolina University, Greenville, North Carolina, United States
  • Dayton Physicians, Kettering, Ohio, United States
  • Oregon Urology Institute, Springfield, Oregon, United States
  • Carolina Urologic Research Center, Myrtle Beach, South Carolina, United States
  • Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Univ of Texas Southwest Med Center, Dallas, Texas, United States
  • Rio Grande Urology, El Paso, Texas, United States
  • Virginia Oncology Associates, Norfolk, Virginia, United States
  • Blue Ridge Cancer Center, Wytheville, Virginia, United States
  • Novartis Investigative Site, CABA, Buenos Aires, Argentina
  • Novartis Investigative Site, CABA, Argentina
  • Novartis Investigative Site, Caba, Argentina
  • Novartis Investigative Site, Darlinghurst, New South Wales, Australia
  • Novartis Investigative Site, Herston, Queensland, Australia
  • Novartis Investigative Site, Adelaide, South Australia, Australia
  • Novartis Investigative Site, Malvern, Victoria, Australia
  • Novartis Investigative Site, Linz, Austria
  • Novartis Investigative Site, Vienna, Austria
  • Novartis Investigative Site, Aalst, Belgium
  • Novartis Investigative Site, Ghent, Belgium
  • Novartis Investigative Site, Wilrijk, Belgium
  • Novartis Investigative Site, São Paulo, São Paulo, Brazil
  • Novartis Investigative Site, Calgary, Alberta, Canada
  • Novartis Investigative Site, Halifax, Nova Scotia, Canada
  • Novartis Investigative Site, London, Ontario, Canada
  • Novartis Investigative Site, Ottawa, Ontario, Canada
  • Novartis Investigative Site, Toronto, Ontario, Canada
  • Novartis Investigative Site, Montreal, Quebec, Canada
  • Novartis Investigative Site, Montreal, Quebec, Canada
  • Novartis Investigative Site, Québec, Quebec, Canada
  • Novartis Investigative Site, Beijing, China
  • Novartis Investigative Site, Guangzhou, China
  • Novartis Investigative Site, Shanghai, China
  • Novartis Investigative Site, Ostrava, Poruba, Czechia
  • Novartis Investigative Site, Olomouc, Czechia
  • Novartis Investigative Site, Prague, Czechia
  • Novartis Investigative Site, Saint-Cloud, Hauts De Seine, France
  • Novartis Investigative Site, Angers, France
  • Novartis Investigative Site, Bordeaux, France
  • Novartis Investigative Site, Bron, France
  • Novartis Investigative Site, Clermont-Ferrand, France
  • Novartis Investigative Site, Rouen, France
  • Novartis Investigative Site, Saint-Herblain, France
  • Novartis Investigative Site, Munich, Bavaria, Germany
  • Novartis Investigative Site, Cologne, North Rhine-Westphalia, Germany
  • Novartis Investigative Site, Aachen, Germany
  • Novartis Investigative Site, Augsburg, Germany
  • Novartis Investigative Site, Berlin, Germany
  • Novartis Investigative Site, Essen, Germany
  • Novartis Investigative Site, Münster, Germany
  • Novartis Investigative Site, Rostock, Germany
  • Novartis Investigative Site, Athens, Greece
  • Novartis Investigative Site, Athens, Greece
  • Novartis Investigative Site, Thessaloniki, Greece
  • Novartis Investigative Site, Debrecen, Hajdu Bihar Megye, Hungary
  • Novartis Investigative Site, Budapest, Hungary
  • Novartis Investigative Site, Budapest, Hungary
  • Novartis Investigative Site, Beersheba, Israel
  • Novartis Investigative Site, Haifa, Israel
  • Novartis Investigative Site, Jerusalem, Israel
  • Novartis Investigative Site, Petah Tikva, Israel
  • Novartis Investigative Site, Tel Aviv, Israel
  • Novartis Investigative Site, Brescia, BS, Italy
  • Novartis Investigative Site, Cona, FE, Italy
  • Novartis Investigative Site, Genova, GE, Italy
  • Novartis Investigative Site, Rozzano, MI, Italy
  • Novartis Investigative Site, Pisa, PI, Italy
  • Novartis Investigative Site, Roma, RM, Italy
  • Novartis Investigative Site, Negrar, VR, Italy
  • Novartis Investigative Site, Milan, Italy
  • Novartis Investigative Site, Kashiwa, Chiba, Japan
  • Novartis Investigative Site, Sapporo, Hokkaido, Japan
  • Novartis Investigative Site, Kobe, Hyōgo, Japan
  • Novartis Investigative Site, Yokohama, Kanagawa-ku, Japan
  • Novartis Investigative Site, Chuo Ku, Tokyo, Japan
  • Novartis Investigative Site, Fukuoka, Japan
  • Novartis Investigative Site, Fukuoka, Japan
  • Novartis Investigative Site, Fukuoka, Japan
  • Novartis Investigative Site, Fukushima, Japan
  • Novartis Investigative Site, Ishikawa, Japan
  • Novartis Investigative Site, Kyoto, Japan
  • Novartis Investigative Site, Petaling Jaya, Selangor, Malaysia
  • Novartis Investigative Site, Kuala Lumpur, Malaysia
  • Novartis Investigative Site, Mexico City, Mexico City, Mexico
  • Novartis Investigative Site, Huxquilucan, Mexico
  • Novartis Investigative Site, Amsterdam, Netherlands
  • VA Caribbean Healthcare System, San Juan, Puerto Rico
  • Novartis Investigative Site, Singapore, Singapore
  • Novartis Investigative Site, Singapore, Singapore
  • Novartis Investigative Site, Bratislava, Slovakia
  • Novartis Investigative Site, Košice, Slovakia
  • Novartis Investigative Site, Nitra, Slovakia
  • Novartis Investigative Site, Trenčín, Slovakia
  • Novartis Investigative Site, Granada, Andalusia, Spain
  • Novartis Investigative Site, Barcelona, Catalonia, Spain
  • Novartis Investigative Site, El Palmar, Murcia, Spain
  • Novartis Investigative Site, Barcelona, Spain
  • Novartis Investigative Site, Madrid, Spain
  • Novartis Investigative Site, Madrid, Spain
  • Novartis Investigative Site, Seville, Spain
  • Novartis Investigative Site, Valencia, Spain
  • Novartis Investigative Site, Geneva, Switzerland
  • Novartis Investigative Site, Lucerne, Switzerland
  • Novartis Investigative Site, Zurich, Switzerland
  • Novartis Investigative Site, Taipei, Taiwan
  • Novartis Investigative Site, Taipei, Taiwan
  • Novartis Investigative Site, Taipei, Taiwan
  • Novartis Investigative Site, Taoyuan District, Taiwan
  • Novartis Investigative Site, Bristol, Avon, United Kingdom
  • Novartis Investigative Site, Guildford, Surrey, United Kingdom
  • Novartis Investigative Site, Sutton, Surrey, United Kingdom
  • Novartis Investigative Site, Coventry, United Kingdom
  • Novartis Investigative Site, London, United Kingdom
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)